• 1
    Armstrong GT. Long-term survivors of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study. Eur J Paediatr Neurol. 2010; 14: 298-303.
  • 2
    Darby SC, McGale P, Taylor CW, et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005; 6: 557-565.
  • 3
    Meadows AT, Friedman DL, Neglia JP, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009; 27: 2356-2362.
  • 4
    Brodin NP, Rosenschold PM, Aznar MC, et al. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncol. 2011; 50: 806-816.
  • 5
    Schneider U, Zwahlen D, Ross D, et al. Estimation of radiation-induced cancer from 3-dimensional dose distributions: concept of organ equivalent dose. Int J Radiat Oncol Biol Phys. 2005; 61: 1510-1515.
  • 6
    Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. On the basis of the November 2010 SEER data submission, posted to the SEER web site 2011. Bethesda, MD: National Cancer Institute; 2011. Available at: Accessed June 14, 2001.
  • 7
    Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2008; 100: 1368-1379.
  • 8
    Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003; 290: 465-475.
  • 9
    Kenney LB, Yasui Y, Inskip PD, et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med. 2004; 141: 590-597.
  • 10
    Travis LB, Gilbert E. Lung cancer after Hodgkin lymphoma: the roles of chemotherapy, radiotherapy and tobacco use. Radiat Res 2005; 163: 695696.
  • 11
    Swerdlow AJ, Barber AJ, Hudson GV, et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol. 2000; 18: 498-509.
  • 12
    Bassal M, Mertens AC, Taylor L, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006; 24: 476-483.
  • 13
    Bhatti P, Veiga LH, Ronckers CM, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res. 2010; 174: 741-752.
  • 14
    van den Belt-Dousebout AW, Aleman BM, Besseling G, et al. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys. 2009; 75: 1420-1429.
  • 15
    Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort [serial online]. BMJ. 2009; 339: b4606.
  • 16
    Centers for Disease Control and Prevention. National Center for Health Statistics. Health Data Interactive. Available at: Accessed January 11, 2011.
  • 17
    Lannering B, Rutkowski S, Gustafsson G, et al. HIT-SIOP PNET4: a randomized multicentre study of hyperfractionated versus conventional radiotherapy in children with standard risk medulloblastoma [abstract]. Pediatr Blood Cancer. 2008; 50( suppl): 45-46.
  • 18
    Newhauser WD, Fontenot JD, Mahajan A, et al. The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol. 2009; 54: 2277-2291.
  • 19
    International Commission on Radiological Protection (ICRP). Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (w). Report no. 92. Oxford, United Kingdom: International Commission on Radiological Protection; 2003.
  • 20
    Travis LB, Hill D, Dores GM, et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst. 2005; 97: 1428-1437.
  • 21
    Yeh JM, Nekhlyudov L, Goldie SJ, et al. A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Ann Intern Med. 2010; 152: 409-408.
  • 22
    Mu X, Bjork-Eriksson T, Nill S, et al. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study. Acta Oncol. 2005; 44: 554-562.
  • 23
    Miralbell R, Lomax A, Cella L, et al. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys. 2002; 54: 824-829.
  • 24
    Geenen MM, Bakker PJ, Kremer LC, et al. Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy. Pediatr Blood Cancer. 2010; 55: 690-697.
  • 25
    Lundkvist J, Ekman M, Ericsson SR, et al. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer. 2005; 103: 793-801.